Young Nam Kwon, MD, PhD; Boram Kim, MS; Jun-Soon Kim, MD; et al.
This cohort study evaluates if the time to treat the first acute attack of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is associated with the disease course and seronegative conversion of anti–myelin oligodendrocyte glycoprotein immunoglobulin G.